SCID-话题@MedSci - 梅斯（MedSci）

#SCID#

7篇内容 | 1020人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1978057, encodeId=2d9a19e8057eb, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）, objectType=article, longId=204325, objectId=737c20432583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=737c20432583, replyNumber=0, likeNumber=64, createdTime=2021-07-25, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=737c20432583, moduleTitle=ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=737c20432583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978058, encodeId=9d8e19e8058a8, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=Blood：腺苷脱氨酶重度联合免疫缺陷(ADA SCID)患者基因治疗后的长期预后, objectType=article, longId=212666, objectId=66fb2126667e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66fb2126667e, replyNumber=0, likeNumber=74, createdTime=2021-06-20, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66fb2126667e, moduleTitle=Blood：腺苷脱氨酶重度联合免疫缺陷(ADA SCID)患者基因治疗后的长期预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66fb2126667e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978055, encodeId=8eb219e805574, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=基因疗法OTL-101治疗ADA-SCID的可行性, objectType=article, longId=160998, objectId=65be1609988b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65be1609988b, replyNumber=0, likeNumber=71, createdTime=2020-01-03, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65be1609988b, moduleTitle=基因疗法OTL-101治疗ADA-SCID的可行性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=65be1609988b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978056, encodeId=834819e805683, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=NEJM：慢病毒基因治疗联合低剂量白消安治疗SCID-X1婴儿, objectType=article, longId=164523, objectId=3c081645237c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c081645237c, replyNumber=0, likeNumber=63, createdTime=2020-03-09, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c081645237c, moduleTitle=NEJM：慢病毒基因治疗联合低剂量白消安治疗SCID-X1婴儿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3c081645237c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978054, encodeId=af9f19e8054c7, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, objectType=article, longId=137448, objectId=21c913e448d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c913e448d2, replyNumber=0, likeNumber=76, createdTime=2018-05-08, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c913e448d2, moduleTitle=Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=21c913e448d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978053, encodeId=c1ad19e8053b5, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=一起为爱，守护未来 ——华大医学&华大公益基金重症联合免疫缺陷（SCID）免费配型检测项目启动, objectType=article, longId=133125, objectId=143e133125a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=143e133125a9, replyNumber=0, likeNumber=74, createdTime=2018-11-16, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=143e133125a9, moduleTitle=一起为爱，守护未来 ——华大医学&华大公益基金重症联合免疫缺陷（SCID）免费配型检测项目启动, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=143e133125a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978052, encodeId=800319e805212, content=<a href='/topic/show?id=e05b1599608' target=_blank style='color:#2F92EE;'>#SCID#</a>, objectTitle=基因治疗新篇章！葛兰素史克干细胞基因疗法Strimvelis获欧盟批准治疗ADA-SCID, objectType=article, longId=70013, objectId=d881e0013dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d881e0013dd, replyNumber=0, likeNumber=77, createdTime=2016-09-28, rootId=0, userName=xugumin, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d881e0013dd, moduleTitle=基因治疗新篇章！葛兰素史克干细胞基因疗法Strimvelis获欧盟批准治疗ADA-SCID, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d881e0013dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SCID

2020-05-29

xugumin (审核中...)

前往app查看评论内容

#SCID#

ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）

2021-07-25

xugumin (审核中...)

前往app查看评论内容

#SCID#

Blood：腺苷脱氨酶重度联合免疫缺陷(ADA SCID)患者基因治疗后的长期预后

2021-06-20

xugumin (审核中...)

前往app查看评论内容

#SCID#

基因疗法OTL-101治疗ADA-SCID的可行性

2020-01-03

xugumin (审核中...)

前往app查看评论内容

#SCID#

NEJM：慢病毒基因治疗联合低剂量白消安治疗SCID-X1婴儿

2020-03-09

xugumin (审核中...)

前往app查看评论内容

#SCID#

Blood：B细胞在体外对IL-21的反应或可作为IL2RG/JAK3缺陷 SCID患者进行异基因造血干细胞移植后体液免疫的生物标志物

2018-05-08

xugumin (审核中...)

前往app查看评论内容

#SCID#

一起为爱，守护未来 ——华大医学&华大公益基金重症联合免疫缺陷（SCID）免费配型检测项目启动

2018-11-16

xugumin (审核中...)

前往app查看评论内容

#SCID#

基因治疗新篇章！葛兰素史克干细胞基因疗法Strimvelis获欧盟批准治疗ADA-SCID

2016-09-28

科室
- - 订阅+
  - 更多科室
工具
服务